FINWIRES · TerminalLIVE
FINWIRES

European Stocks Tracking Higher in Friday Trading Amid US-Iran Ceasefire Talks; German Inflation Rises in March

-- The European stock markets were moving modestly higher Friday amid reports that US and Iran ceasefire negotiators will meet in Islamabad, Pakistan, on Saturday.

The Stoxx Europe was up 0.5%, Germany's DAX was rising 0.2%, the FTSE 100 was increasing 0.1%, France's CAC was gaining 0.3%, and the Swiss Market Index was moving 0.3% higher.

Mining stocks were tracking higher as Antofagasta and Fresnillo were rising 3.4% and 2.1% respectively in London, while Heidelberg Materials gained 3.2% in Frankfurt. ArcelorMittal was up 2.8% in Paris, and Boliden rose 2.1% in Stockholm.

The inflation rate in Germany, as measured by the annual change in the consumer price index, surged in March to 2.7% from 1.9% in February, according to the Federal Statistical Office (Destatis). It's the highest rate since January 2024 when the CPI was 2.9%.

"The significant increase in the prices of energy products is driving up inflation," Destatis President Ruth Brand said in a statement. "In particular, motor fuel and heating oil prices have risen sharply for consumers since the start of the Iran war."

And in corporate news, Switzerland's criminal court said Friday it has discontinued a proceeding against UBS in connection with alleged money laundering in a case involving Mozambican state-owned companies.

The case stemmed from alleged criminal behavior by Credit Suisse, which UBS took over following its 2023 collapse.

The court cited "procedural obstacles" for abandoning the case, "because Credit Suisse lost [its status] as a criminal legal entity through the merger with UBS," according to a translation of the official statement.

"We welcome the court's recognition that UBS cannot be held liable in this matter, as such liability cannot be transferred to a legal successor through a merger," a UBS spokesperson toldin an emailed statement.

Shares of the Swiss bank were moving 1% higher in Zurich.

TotalEnergies said Friday the SATORP refinery in Saudi Arabia was impacted by the recent Middle East conflict, damaging a processing train.

Although there were no casualties, the units were shut down as a safety precaution, the company said. SATORP is jointly owned by TotalEnergies and Saudi state oil giant Aramco.

Shares of the French oil and gas company were off 1% in Paris.

GSK has withdrawn its application for a drug supported by President Donald Trump as a potential treatment for autism symptoms, the Wall Street Journal reported Thursday, citing a regulatory filing.

The British drugmaker asked the US Food and Drug Administration to pull out its application for the drug leucovorin calcium as it does not market the medicine, months after submitting it at the request of health officials.

Shares of the British pharmaceutical company were increasing 0.7% in London.

HSBC and Anchorpoint Financial, a Standard Chartered joint venture, have been granted stablecoin issuer licenses by the Hong Kong Monetary Authority, the regulator said Friday.

The licenses have been granted under the stablecoins ordinance to issue stablecoins in Hong Kong, according to the regulator. The licensees plan to complete the required documentation and launch business in the coming few months, the Monetary Authority said.

Shares of the British bank were up 0.5% in London.

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB